Urgent.ly (NASDAQ: ULY) warned its stock is subject to Nasdaq delisting
Rhea-AI Filing Summary
Urgent.ly Inc. reports that Nasdaq has notified the company its common stock is subject to delisting from The Nasdaq Capital Market. The action follows a prior notice that Urgent.ly no longer meets Nasdaq Listing Rule 5550(b) because net income from continuing operations, and alternative measures such as market value of listed securities or stockholders’ equity, are below required levels.
Nasdaq has informed the company that its securities are scheduled to be delisted at the open of business on September 25, 2025, unless Urgent.ly requests a hearing before a Nasdaq Hearings Panel. The company plans to request this hearing, which will automatically pause further delisting action while the panel considers its plan and any extension. Urgent.ly will present strategies to regain compliance, but there is no assurance the panel will grant continued listing or that the company will meet the standards within any extension.
Positive
- None.
Negative
- Nasdaq delisting risk escalates: Nasdaq has notified Urgent.ly that its securities are subject to delisting on September 25, 2025 due to continued non-compliance with Listing Rule 5550(b), and there is no assurance a hearings panel will grant continued listing or that the company will regain compliance within any extension.
Insights
Nasdaq has moved Urgent.ly to a formal delisting process, with only panel relief now standing between the stock and removal from the exchange.
Urgent.ly Inc. discloses that Nasdaq staff has determined its common stock is subject to delisting from The Nasdaq Capital Market because it remains out of compliance with Listing Rule 5550(b) on net income and alternative criteria. The notice states that, absent further action, the securities will be delisted at the open of business on
The company plans to request a hearing before a Nasdaq Hearings Panel, which will automatically stay delisting at least through the hearing and any extension period the panel may grant. At that hearing, management intends to present a plan to demonstrate compliance with the continued listing standards, and the company states it is actively pursuing strategies to meet the rule. However, the disclosure explicitly notes there can be no assurance the panel will approve continued listing or that compliance will be achieved within any extension period.
This development increases listing risk for shareholders, since continued trading on Nasdaq now depends on both panel discretion and the company’s ability to improve metrics tied to Rule 5550(b). Future company filings and the referenced press release dated